📰 Prostate News
Page 73 - Prostate News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prostate. Real-time updates on events, politics, business and more.
June 1, 2023
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer, according to a multi-center study led by UC San Francisco and Stanford University.
May 30, 2023
- POSLUMA will be commercially available in the United States in early June 2023 - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative
May 30, 2023
MyJournals.org - Science - Regional disparities of prostate cancer mortality in Ecuador: an examination of trends and correlates from 2004 to 2019 (BMC Public Health)
May 30, 2023
MyJournals.org - Science - IJMS, Vol. 24, Pages 9462: Transcriptome-Wide Analysis of Low-Concentration Exposure to Bisphenol A, S, and F in Prostate Cancer Cells (International Journal of Molecular Sciences)
May 29, 2023
MyJournals.org - Science - Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report (Journal of Medical Case Reports)
May 29, 2023
MyJournals.org - Science - IJMS, Vol. 24, Pages 9420: Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5 (International Journal of Molecular Sciences)
May 29, 2023
Researchers at Baylor College of Medicine have discovered a crucial regulator of the anti-cancer immune response that could change the game in the fight against cancer.
May 26, 2023
If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as [18F]-DCFPyL) will offer prostate cancer patients access to a diagnostic imaging agent more sensitive than conventional imaging.Proven
May 23, 2023
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology's annual meeting.
May 23, 2023
PARIS, May 23, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has completed enrollment in its USA-led SOLAR Phase 1/2 study evaluating the safety, biodistribution